Viewing nowCiprofloxacin Tablet 250 mg (Ciprofloxacin Hydrochloride Monohydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

MFDS item code 199100750 · Notified 1991.03.27 · Insurance code 642702110
Treatment of infections of the genitourinary tract, respiratory tract, ear, nose and throat, eyes, abdomen, skin, and bones and joints
This medication is used to treat various infections caused by different bacteria such as Escherichia coli, Shigella, and Salmonella. It is effective against respiratory infections excluding acute bronchitis and community-acquired pneumonia, as well as infections of the ear, nose, and throat. It is also used for urogenital infections such as bacterial prostatitis, acute urinary tract infections, and gonococcal cervicitis and urethritis. Additionally, it helps with gastrointestinal infections, infections of the biliary tract, skin and soft tissue infections, and osteoarticular infections. It has therapeutic effects on gynecological infections, peritonitis, fistula infections, and chalazia. This drug is used carefully for certain infections due to the potential for severe adverse reactions. It is effectively used for the treatment of various bacterial infections.
(Tablets) ○ Adults: The usual dose is 250 ~ 500 mg of ciprofloxacin per dose, administered orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days; continue administration for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.
This medication can cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system disorders. Special caution should be taken for patients with myasthenia gravis as there is a risk of symptom exacerbation. This drug should only be used for specific infections such as acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, chronic obstructive pulmonary disease, simple urinary tract infections, and acute otitis media when there are no alternative treatment options available. Older adults, patients with impaired renal function, and those with certain central nervous system diseases should use this medication more cautiously. It is not recommended for use in pregnant or possibly pregnant women, nursing mothers, and individuals under 18 years of age. The risk of tendon rupture is increased when this drug is taken in combination with corticosteroids, therefore, they should not be taken together, and if pain or inflammation occurs, use should be stopped immediately and medical consultation sought. Neurological symptoms such as seizures, dizziness, insomnia, hallucinations, and depression may occur; if these symptoms arise, the healthcare provider should be informed immediately. Additionally, this medication can affect blood sugar control, so diabetic patients should monitor their blood sugar levels closely. This drug can interact with various medications, so if you are taking other medications, you must inform your healthcare provider, especially when taking theophylline, warfarin, diabetes medications, tizanidine, and ketoprofen. During treatment, strong sunlight and UV exposure should be avoided, and if a skin rash or itching occurs, use should be discontinued. If severe diarrhea or bloody stools appear, there is a possibility of pseudomembranous colitis, and immediate medical consultation is necessary. Overdose may cause renal function problems, so the prescribed dosage and frequency must be strictly adhered to. Finally, this drug is not for use in children and growing adolescents and should be stored in a location inaccessible to children, protected from direct sunlight.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, inappropriate secretion of antidiuretic hormone syndrome, allergic reactions, allergic edema, angioedema, anaphylactic reactions, shock resembling anaphylaxis, serum sickness-like reactions, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory reduction, loss of taste, tremors, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hyperreactivity, increased intracranial pressure, impaired coordination, peripheral neuropathy, polyneuropathy, vision disorders, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular arrhythmias, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, loss of appetite, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, pseudomembranous colitis, colitis associated with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, hepatic dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, drug-induced erythema, mucocutaneous syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, weakness, edema, sweating, gait disorders, papular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, interstitial pneumonia, visual impairment
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is recommended to keep it in a cool room out of direct sunlight.
White or yellowish round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SS Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.